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ABSTRACT  Purpose: The authors present a prospective study on 10 patients with stereotactic infusion of
tissue plasminogen activator (rtPA) intraparenchimal hemorrhage. Methods: Between 1999 and 2000, 10
patients with deep seated hematomas in the basal ganglia were selected for stereotactic infusion of rtPA and
spontaneous clot drainage. Results: All cases had about 80% reduction of the hematoma volume in the CT
scan at the third day. The intracranial pressure was normalized by the third day too. There were no local or
systemic complications with the use of this trombolitic. The results were shown by the Glasgow Outcome
Scale with six patients in V, three in IV and one in III after 3 months. Conclusion: Early treatment and drainage
with minimally invasive neurosurgery , can make these patients with deep-seated hematomas recover the
consciousness and they can be rehabilitated earlier avoiding secondary complications.
KEY WORDS: hematoma lysis, recombinant tissue plasminogen activator, spontaneous intracerebral hematoma,
stereotaxy.
Fibrinólise com infusão de rtPA e drenagem estereotáxica de hematoma intracerebral espontâneo
profundo
RESUMO  Objetivo: Estudo prospectivo em 10 pacientes com infusão de trombolítico (rtPA) dentro do
hematoma cerebral profundo supratentorial e drenagem estereotáxica. Método: Entre 1999 e 2000 10 pacientes
com hematomas de profundidade foram selecionados para infusão de rtPA e drenagem do coágulo espontânea.
Resultado: Todos os casos obtiveram 80% de redução do volume do hematoma medidos por TC no terceiro
dia. A pressão intracraniana estava normalizada no terceiro dia. Não houve complicações locais ou sistêmicas
relacionadas com o uso deste trombolítico. Os resultados comparados foram mostrados pela Escala de
Prognóstico de Glasgow com 6 pacientes em GrauV, 3 pacientes em Grau IV e 1 paciente em Grau III após três
meses. Conclusão: Tratamento precoce e drenagem com técnica neurocirúrgica minimamente invasiva pode
fazer estes pacientes terem uma recuperação da consciência mais rápida e assim serem reabilitados mais
precocemente evitando complicações secundárias.
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Spontaneous intracerebral hematomas, as known
as (AKA) hypertensive hemorrhages, especially those
deep-seated, are still highly controversial in terms
of conservative or operative therapy1. Neither non-
operative therapy nor operative management has
been able to reduce the mortality or morbidity, es-
pecially since the classical neurosurgical operation
for deep-seated spontaneous intracerebral hemor-
rhage is a high-risk procedure and controversial.
Surgery is not so controversial if it is in posterior
fossa, because it can promote a fast reduction in
brainstem compression and produces better results.
Backlund et al. and Higgins and Nashold were the
first to report stereotactic evacuation of deep-seated
hemorrhages2,3. They could not complete evacuation
of those clots. Doi et al. and Mohadjer et al. reported
their experience with urokinase infusion through a
stereotactically implanted catheter inserted into the
hematoma cavity4, 5. Shaller et al. published the first
series using tissue plasminogen activator (rtPA)
through a stereotactic catheter implanted with good
outcome and few complications6.
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This prospective study analyzes the efficacy and
safety of clot lysis with rtPA stereotactically infused
and spontaneous drainage of hypertensive deep in-
tracerebral hematoma. Results are compared with
control group and the literature is reviewed.
METHOD
Patient population
Between November 1999 and October 2000 at the
emergency room (ER) of Pró-Cardíaco Hospital, 10 patients
with hypertensive spontaneous basal ganglia hematomas
were selected among 24 patients with deep intracerebral
hematomas. The mean age was 66.4 years (ranging 61 -
74 years) being six males. Six patients were considered
control group. They were not considered surgical candi-
dates because even having hypertensive basal ganglia he-
matomas they presented one of exclusion items described
below.
Informed consent for therapy, approved by PróCardíaco
Hospital ethical committee, was obtained from the pa-
tients and/or their relatives.
Inclusion and exclusion criteria
Patients were selected based on: a) an impairment of
consciousness level; b) no signs of herniation (midbrain
symptoms, wide and fixed pupil); c) hematoma volume
more than 30cc; d) less than 48hs of onset; e) no arterio-
venous malformation (AVM) in digital angiography sus-
pected ; f) no evidence of systemic bleeding disease; g)
Glasgow coma scale (GCS) score not less than 5; e) com-
plete routine laboratory study negative for blood dyscra-
sias, coagulopathies, drug tests, infection and erythrocyte
sedimentation rate as evidence for vasculitis.
Radiological procedures
CT scan was performed in all patients less than 3 hours
of admission. The diameter and thickness of the hematoma
was assessed. Patients whom a vascular malformation was
suspected, an angiography was performed before the he-
matoma lysis.
Operative technique
The stereotactic arc was fixed under local anesthesia.
A stereotomography was performed. Those images were
transferred to the workstation. At the workstation using
the MSPS software (A. Alaminos  Micromar - São Paulo
SP - Brazil) the coordinates for the hematoma center were
acquired. This isocenter was used as our target to insert
the silicone hematoma drainage catheter (Nasser Anti-
Block Catheter  Phoenix  Valley Forge  PA- USA) espe-
cially designed to this protocol. At the same time the co-
ordinates of the lateral ventricle were acquired in order to
insert a silicone ventricular drainage catheter and moni-
tor the intracranial pressure (ICP) and had cerebrospinal
fluid (CSF) drainage in the presence of intracranial hyper-
tension. In the operating room, under local anesthesia
those two catheters were implanted using the ETM-03B
Stereotactic System (Micromar  São Paulo SP  Brazil),
and fixed at the skull. Both catheters were connected in-
dividually with an external closed drainage system. Back
to the neuroradiological suite, a new CT scan was done to
check the correct position of those catheters. The patients
were transferred to the Neuro ICU.
Hematoma lysis protocol
RtPA (Actilyse  Boehringer Ilgelheim - Brazil) infusion
was calculated under Schallers protocol, one milligram
of rt-PA equaled a volume of one milliliter6. It is based on
the data from Lippitz and Shaller showing this volume is
effective and low toxicity6. If the maximum diameter of
the hematoma was 5cm , then 5 mg of rtPA was adminis-
tered. The system was closed for 2 hours and then opened
through a closed drainage system against 0 cm of pres-
sure. The authors did not use hematoma evacuators. The
drainage was kept spontaneous.
CT scan was performed after 24 hours to re-evaluate
the hematoma size and calculate the second rtPA dose.
The catheters were left in place for an additional 48 hours
to drain the residual blood. The ventricular catheter was
removed after 24 hours of normal intracranial pressure.
Follow up
The results were graded according to the Glaslow Out-
come Scale (GOS) ; GOS V, good recovery, GOS IV, moder-
ate disability (independent); GOS III, severe disability (de-
pendent on others); GOS II, vegetative state; GOS I, dead7.
Also a neurologic exam was done to compare the neuro-
logical deficits before and after the procedure in long term.
RESULTS
Table 1 shows 10 patients, admitted at the ER of
Pró-Cardíaco Hospital. The maximum diameter of
those hematomas varied from 4 to 6 cm . All those
patients had deep seated hematomas, being 5 tha-
lamic (3 right and 2 left) and 5 putaminal (3 right
and 2 left). Two patients in whom the history of sys-
temic arterial hypertension was not clear before, both
thalamic underwent subtraction digital angiography
which were both normal.
At the admission the level of consciousness was
related to the hematoma size and location. Five pa-
tients were in GCS less than 8. Seven were hemipa-
retic and among them, 4 were hypertonic.
Six patients presented ventricular clot . Three had
acute hydrocephalus. None needed permanent
shunt. The ventricular drainage system was pro-
grammed to open and drain only if the intracranial
pressure becomes higher than 20mmHg. Otherwise
it worked as a monitoring device. These 3 patients
with acute hydrocephalus the ventricular drainage
volume in each 5 early days exceeded 200ml/day ,
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but after 5 days this volume decreased and after 7
days the volume and the pressure were normalized .
Every patient had a second dose of rt-PA calcu-
lated same way the first . None had a third dose. At
the third day, CT scan showed in all patients reduc-
tion of 80% hematoma volume and less perilesional
edema (Fig 1). The hematoma catheter was left in
place for an additional 48 hours to drain the residual
blood . The volume drained was ranged from 80 to
180 ml of liquefied clot, depending on the hema-
tomas volume.
The ventricular catheter was removed after 24
hours of normal intracranial pressure, usually at the
fifth day and with the aspect of the CSF clear.
Six patients presented fast improvement in their
consciousness, in 48 hours (Fig 2). It was less evi-
dent to observe it in patients with left thalamic clots.
Two patients with left thalamic clot, one right tha-
lamic and one left putaminal had less improvement
in consciousness level.
The mean hospitalizations time was 15 days. Two
patients who stayed longer had left thalamic he-
matoma. There were no dead in this series and no
side effects related with rtPA .
The mean follow up evaluation at 3 months shows
that 6 patients are now in GOS V, 3 patients are in
GOS IV and only one is in GOS III. This patient had a
left thalamic hematoma, his GCS score at the ad-
mission was 6, and was hemiplegic. He is still hemi-
plegic even after 4 months of rehabilitation. Two out
3 in GOS 4 had hemiplegia at the admission and
now they improved to grade 3 and 4 in muscle
Fig 1. Patient 5. Seventy four -year-old man with left hyperten-
sive thalamic hematoma and intraventricular clot. A, CT at ad-
mission. B, CT on day 3 showing significant reduction of the he-
matoma.
Fig 2. Patient 9: Seventy two-year-old woman with right tha-
lamic hematoma and intraventricular clot. A, CT at admission. B,
on day 8 with complete reabsorption of the clot.
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strength scale. Those patients are constantly being
followed by our rehabilitation service.
It is important to mention that all these patients
were admitted in the first 6 hours after ictus. It was ob-
served enlargement of the hematoma from the first
CT until the stereo CT in two thalamic hematomas.
No side effects were observed with this protocol
of rtPA in terms of toxicity or hematoma enlargment.
All patients had some improvement regarding GOS
or neurologic examination
Comparing those surgical patients with control
group (non surgical) it was found: a) mean 10 days
less of hospitalization; b) 3 days of recovering of
consciousness state on surgical against 10 days on
non-surgical; c) morbidity was 25% higher on con-
trol group; d) mortality was 0 on surgical group com-
pared to 30% on control group caused by intracra-
nial hypertension; e) secondary complications were
40% more on control group; f) hospitalization costs
were two times higher on control group; g) GOS
was predominantly III on control group and IV on
surgical.
DISCUSSION
After experimental studies and clinical trials
showed the efficacy and safety of the rtPA instilla-
tion in subarachnoid hemorrhage, lysing the clots,
some authors based on previous experience with
urokinase infusion, started to think about clot lysis
with rtPA8-12 .
The prognosis of thalamic hemorrhage has a close
correlation with hematoma size and ventricular ex-
tension of hemorrhage. Chung et al. demonstrated
that the mortality was 81% when thalamic hemor-
rhage presented the entire area of the thalamus:
global type13. The volume of ventricular blood is an
important determinant of outcome in supratento-
rial intracerebral hemorrhage, as shown by Tuhrim
et al.14.
Reabsorption of hematoma with good neurologi-
cal outcome was observed following stereotactic
infusion of rt-PA for clot lysis and drainage in all those
cases except one in the left thalamus, however on
control group the results were less impressive.
The authors share the idea of Schaller et al., re-
garding pure fibrinolytic trial with careful drainage
instead of forceful hematoma aspiration preventing
secondary bleeding6,15. There is a clear benefit using
rtPA over urokinase. There have been some reports
regarding the neurotoxity of urokinase and new
bleeding related to urokinase overdose16,17. The risk
of using rtPA infusion inside the hematomas is
rebleeding . It has been published, but the right se-
lection of those patients, with careful investigation
of bleeding diseases can be useful to prevent it18.
These patients had a good outcome: 60% (GOS
V) , 30% (GOS IV) and 10% (GOS III), after 3 months
follow-up.
The whole procedure was completed in 3 hours.
Table 1. Clinical data and octcome of 10 patients with spontaneous basal ganglia hematomas.
Patient Sex Age Hematoma size Localization Glasgow coma Glasgow
(years) (diameter in cm) scale admission outcome scale*
1 M 70 5 L Putamen 9 V
2 M 64 5 L Thalamus 6 III
3 F 62 4 R Putamen 9 V
4 F 68 6 R Putamen 6 V
5 M 74 4 L Thalamus 6 IV
6 F 68 4 R Thalamus 7 IV
7 M 61 5 R Putamen 9 V
8 M 62 5 L Putamen 7 V
9 F 72 5 R Thalamus 6 V
10 M 69 4 R Thalamus 8 IV
Data Bank from Department of Neurosurgery, Pró-Cardiaco Hospital  Rio de Janeiro  RJ  Brasil.
Glasgow outcome scale (GOS): GOS V (good recovery); Gos IV (moderate disability); GOS III (severe disability  depen-
dent of others); GOS II (vegetative state); GOS I (dead). *GOS after 3 months.
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We know from the literature that during the early
period after the ictus, intracerebral hematomas may
cause neurological deterioration as a result of an
increasing mass effect caused by surrounding edema,
and this can last up to 4 weeks19,20. The good out-
come in these patients could be explained due the
fact that admission and diagnosis took about 4
hours. Also it seems that in eloquent areas, some
deficits are related with the ischemic caused by the
mass effect of the hematoma in the surround areas.
These results suggest that this procedure is safe,
effective on selected patients. Early treatment and
evacuation, with stereotactic minimally invasive neu-
rosurgery, could make these patients, with deep-
seated hematomas, have a recovery of the conscious-
ness state and this way they could be rehabilitated
soon, helping them having less secondary compli-
cations.
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